MS4A1 and metastatic malignant neoplasm in the lymph nodes: MS4A1 was expressed higher in women and the older (>65 years), stage N0, stage T1&T2, and stage I&II patients, while in the patients with lymph-node metastasis and advanced TNM stage, OAS1 had higher expression.